Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Strepsils with lidocaine is an over-the-counter throat lozenge and oral spray combination product used for the symptomatic relief of sore throat, mouth infections, and oropharyngeal pain. It contains three active ingredients: two mild antiseptics, amylmetacresol and dichlorobenzyl alcohol, which help combat bacterial and viral pathogens in the mouth and throat, and lidocaine hydrochloride, a local anesthetic of the amide type that provides rapid pain relief by numbing the throat. Originally developed by Boots Healthcare and later acquired by Reckitt, this combination is widely used to alleviate discomfort associated with pharyngitis, tonsillitis, and minor mouth sores.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amylmetacresol + dichlorobenzyl alcohol + lidocaine.